Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Revenue

In the year 2025, Shanghai Serum Bio-Technology had annual revenue of 196.21M CNY with 0.66% growth. Shanghai Serum Bio-Technology had revenue of 21.07M in the quarter ending December 31, 2025, a decrease of -2.58%.

• Revenue: 196.21M
• Revenue Growth: +0.66%
• P/S Ratio: 13.39
• Revenue / Employee: 601.86K
• Employees: 324
• Market Cap: 2.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	196.21M	1.29M	0.66%
Dec 31, 2024	194.92M	4.77M	2.51%
Dec 31, 2023	190.14M	15.92M	9.14%
Dec 31, 2022	174.22M	-34.47M	-16.52%
Dec 31, 2021	208.69M	23.13M	12.47%